Susheel Varma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susheel Varma has a total of 425 co-authors. Here are the top co-authors by number of shared publications:
- John Dylan Spalding
European Bioinformatics Institute, European Molecular Biology Laboratory, Wellcome Genome Campus, Hinxton, Cambridge, UK
5 shared publications - Paul Flicek
European Molecular Biology Laboratory, European Bioinformatics Institute
5 shared publications - Serena Scollen
ELIXIR Hub, Wellcome Genome Campus, Hinxton, Cambridge, UK
5 shared publications - Alejandro Federico Frangi
University of Manchester
4 shared publications Angela Page
Global Alliance for Genomics and Health, Toronto, Ontario, Canada
4 shared publications- Gary Saunders
ELIXIR Hub, Wellcome Genome Campus, Hinxton, Cambridge, UK
4 shared publications
Latest Publications
- Open Access
The GA4GH Workflow Execution Service: A Standard API for Workflow Execution and Management in Genomics
Motivation: Rapid growth in life science data generation has led to large and increasingly distributed collections of sensitive genomic data. To analyse this data, researchers increasingly rely on computational workflows to enable scalable, portable and reproducible analysis. However, these workflows are executed by specialized workflow engines across heterogeneous compute environments, each with its own requirements. As a result, users often need engine- and compute-environment-specific knowledge to submit, monitor and manage workflow execution, increasing the barriers to interoperability. These challenges are compounded in large-scale projects, where workflow runs must be dispatched to local clusters, cloud platforms or data hosting infrastructures with different underlying technologies. Results: We describe the Global Alliance for Genomics and Health (GA4GH) Workflow Execution Service (WES) API, an approved GA4GH standard first released in 2018, together with its data model and the endpoints that define a unified interface for workflow execution. By standardizing workflow invocation, the WES API allows a single client to submit, monitor and cancel workflow runs across diverse workflow engines and compute backends, such as scheduling clusters or cloud platforms. We surveyed thirteen adoptions of the standard, covering standalone services and platforms in four programming languages. In a two-site demonstration, a WES implementation from Germany and one from Japan executed the same federated allele-frequency analysis with site-specific adjustments and only aggregated results leaving either site, demonstrating that it is possible to run the same analysis across independently built and operated WES services in different countries. From the gaps identified, we propose extensions for community discussion. Availability and implementations: The latest version of the WES API repository can be found at https://github.com/ga4gh/workflow-execution-service-schemas (DOI: https://doi.org/10.59756/m382x-ww ). The full Reference Documentation can be viewed at: https://ga4gh.github.io/workflow-execution-service-schemas/docs/ Contact: valentin.schneider-lunitz@bih-charite.de
Open AccessThe GA4GH Workflow Execution Service: A Standard API for Workflow Execution and Management in Genomics
Motivation: Rapid growth in life science data generation has led to large and increasingly distributed collections of sensitive genomic data. To analyse this data, researchers increasingly rely on computational workflows to enable scalable, portable and reproducible analysis. However, these workflows are executed by specialized workflow engines across heterogeneous compute environments, each with its own requirements. As a result, users often need engine- and compute-environment-specific knowledge to submit, monitor and manage workflow execution, increasing the barriers to interoperability. These challenges are compounded in large-scale projects, where workflow runs must be dispatched to local clusters, cloud platforms or data hosting infrastructures with different underlying technologies. Results: We describe the Global Alliance for Genomics and Health (GA4GH) Workflow Execution Service (WES) API, an approved GA4GH standard first released in 2018, together with its data model and the endpoints that define a unified interface for workflow execution. By standardizing workflow invocation, the WES API allows a single client to submit, monitor and cancel workflow runs across diverse workflow engines and compute backends, such as scheduling clusters or cloud platforms. We surveyed thirteen adoptions of the standard, covering standalone services and platforms in four programming languages. In a two-site demonstration, a WES implementation from Germany and one from Japan executed the same federated allele-frequency analysis with site-specific adjustments and only aggregated results leaving either site, demonstrating that it is possible to run the same analysis across independently built and operated WES services in different countries. From the gaps identified, we propose extensions for community discussion. Availability and implementations: The latest version of the WES API repository can be found at https://github.com/ga4gh/workflow-execution-service-schemas (DOI: https://doi.org/10.59756/m382x-ww ). The full Reference Documentation can be viewed at: https://ga4gh.github.io/workflow-execution-service-schemas/docs/ Contact: valentin.schneider-lunitz@bih-charite.de
- 13 October 2026
- Published by Global Alliance for Genomics and Health Inc.
Workflow Execution Service (WES)
The WES API is a standard way to run and manage portable workflows.
- 13 October 2026
- Published by Global Alliance for Genomics and Health Inc.
Workflow Execution Service (WES)
The WES API is a standard way to run and manage portable workflows.
- Open Access
- 23 September 2025
A decentralized future for the open-science databases
The continuous and reliable open access to curated biological data repositories is indispensable for accelerating rigorous scientific inquiry and fostering reproducible research outcomes. However, the current paradigm, which relies heavily on centralized infrastructure for the storage and distribution of foundational biomedical datasets, inherently introduces significant vulnerabilities. This centralized model is susceptible to single points of failure, including cyberattacks, technical malfunctions, natural disasters, and even political or funding uncertainties. Such disruptions can lead to widespread data unavailability, data loss, integrity compromises, and substantial delays in critical research, ultimately impeding scientific progress. The downstream effect of such interruptions can be the widespread paralysis of diverse research activities, including computational, clinical, molecular, and climate studies. This scenario vividly illustrates the inherent dangers of consolidating essential scientific resources within a single geopolitical or institutional locus. As data generation is accelerating and the global landscape continues to fluctuate, the sustainability of centralized models must be critically re-evaluated. A shift toward federated and decentralized architectures may offer a robust and forward-looking approach to enhancing the resilience of scientific data infrastructures by reducing exposure to governance instability, infrastructural fragility, and funding volatility, while also promoting equity and global accessibility. Inspired by established models such as ELIXIR’s federated infrastructure and the policy and funding frameworks developed by CODATA and the Global Biodata Coalition (GBC), emerging Decentralized Science (DeSci) initiatives can contribute to building more resilient, fair, and incentive-aligned data ecosystems. The future of open science depends on integrating these complementary approaches to establish a globally distributed, economically sustainable, and institutionally robust infrastructure that safeguards scientific data as a public good, further ensuring continued accessibility, interoperability, and preservation for generations to come. Here, we examine the structural limitations of centralized repositories, evaluate federated and decentralized models, and propose a hybrid framework for resilient, fair, and sustainable scientific data stewardship.
- 23 September 2025
Open AccessA decentralized future for the open-science databases
The continuous and reliable open access to curated biological data repositories is indispensable for accelerating rigorous scientific inquiry and fostering reproducible research outcomes. However, the current paradigm, which relies heavily on centralized infrastructure for the storage and distribution of foundational biomedical datasets, inherently introduces significant vulnerabilities. This centralized model is susceptible to single points of failure, including cyberattacks, technical malfunctions, natural disasters, and even political or funding uncertainties. Such disruptions can lead to widespread data unavailability, data loss, integrity compromises, and substantial delays in critical research, ultimately impeding scientific progress. The downstream effect of such interruptions can be the widespread paralysis of diverse research activities, including computational, clinical, molecular, and climate studies. This scenario vividly illustrates the inherent dangers of consolidating essential scientific resources within a single geopolitical or institutional locus. As data generation is accelerating and the global landscape continues to fluctuate, the sustainability of centralized models must be critically re-evaluated. A shift toward federated and decentralized architectures may offer a robust and forward-looking approach to enhancing the resilience of scientific data infrastructures by reducing exposure to governance instability, infrastructural fragility, and funding volatility, while also promoting equity and global accessibility. Inspired by established models such as ELIXIR’s federated infrastructure and the policy and funding frameworks developed by CODATA and the Global Biodata Coalition (GBC), emerging Decentralized Science (DeSci) initiatives can contribute to building more resilient, fair, and incentive-aligned data ecosystems. The future of open science depends on integrating these complementary approaches to establish a globally distributed, economically sustainable, and institutionally robust infrastructure that safeguards scientific data as a public good, further ensuring continued accessibility, interoperability, and preservation for generations to come. Here, we examine the structural limitations of centralized repositories, evaluate federated and decentralized models, and propose a hybrid framework for resilient, fair, and sustainable scientific data stewardship.
- Open Access
- 15 April 2024
- Published by PubPub
The NIH just released the Draft 2023-2028 Strategic Plan for Data Science. Here are the Benefits, Gaps and Opportunities
The NIH is soliciting feedback from the biomedical community. Here's what we think.
- 15 April 2024
- Published by PubPub
Open AccessThe NIH just released the Draft 2023-2028 Strategic Plan for Data Science. Here are the Benefits, Gaps and Opportunities
The NIH is soliciting feedback from the biomedical community. Here's what we think.
- Open Access
Evaluation of freely available data profiling tools for health data research application: a functional evaluation review
Objectives To objectively evaluate freely available data profiling software tools using healthcare data. Design Data profiling tools were evaluated for their capabilities using publicly available information and data sheets. From initial assessment, several underwent further detailed evaluation for application on healthcare data using a synthetic dataset of 1000 patients and associated data using a common health data model, and tools scored based on their functionality with this dataset. Setting Improving the quality of healthcare data for research use is a priority. Profiling tools can assist by evaluating datasets across a range of quality dimensions. Several freely available software packages with profiling capabilities are available but healthcare organisations often have limited data engineering capability and expertise. Participants 28 profiling tools, 8 undergoing evaluation on synthetic dataset of 1000 patients. Results Of 28 potential profiling tools initially identified, 8 showed high potential for applicability with healthcare datasets based on available documentation, of which two performed consistently well for these purposes across multiple tasks including determination of completeness, consistency, uniqueness, validity, accuracy and provision of distribution metrics. Conclusions Numerous freely available profiling tools are serviceable for potential use with health datasets, of which at least two demonstrated high performance across a range of technical data quality dimensions based on testing with synthetic health dataset and common data model. The appropriate tool choice depends on factors including underlying organisational infrastructure, level of data engineering and coding expertise, but there are freely available tools helping profile health datasets for research use and inform curation activity.
Open AccessEvaluation of freely available data profiling tools for health data research application: a functional evaluation review
Objectives To objectively evaluate freely available data profiling software tools using healthcare data. Design Data profiling tools were evaluated for their capabilities using publicly available information and data sheets. From initial assessment, several underwent further detailed evaluation for application on healthcare data using a synthetic dataset of 1000 patients and associated data using a common health data model, and tools scored based on their functionality with this dataset. Setting Improving the quality of healthcare data for research use is a priority. Profiling tools can assist by evaluating datasets across a range of quality dimensions. Several freely available software packages with profiling capabilities are available but healthcare organisations often have limited data engineering capability and expertise. Participants 28 profiling tools, 8 undergoing evaluation on synthetic dataset of 1000 patients. Results Of 28 potential profiling tools initially identified, 8 showed high potential for applicability with healthcare datasets based on available documentation, of which two performed consistently well for these purposes across multiple tasks including determination of completeness, consistency, uniqueness, validity, accuracy and provision of distribution metrics. Conclusions Numerous freely available profiling tools are serviceable for potential use with health datasets, of which at least two demonstrated high performance across a range of technical data quality dimensions based on testing with synthetic health dataset and common data model. The appropriate tool choice depends on factors including underlying organisational infrastructure, level of data engineering and coding expertise, but there are freely available tools helping profile health datasets for research use and inform curation activity.
- Top Cited PapersOpen Access
- 10 November 2021
- Published by Elsevier in Cell Genomics
- Vol. 1 (2)
GA4GH: International policies and standards for data sharing across genomic research and healthcare
- 10 November 2021
- Published by Elsevier in Cell Genomics
- Vol. 1 (2)
Top Cited PapersOpen AccessGA4GH: International policies and standards for data sharing across genomic research and healthcare
- Top Cited PapersOpen Access
- 10 November 2021
- Published by Elsevier in Cell Genomics
- Vol. 1 (2)
The Data Use Ontology to streamline responsible access to human biomedical datasets
- 10 November 2021
- Published by Elsevier in Cell Genomics
- Vol. 1 (2)
Top Cited PapersOpen AccessThe Data Use Ontology to streamline responsible access to human biomedical datasets
- Open Access
Analysis of Data Use Registers published by health data custodians in the UK
Transparency of how health and social care data is used by researchers is crucial to building public trust. We define “data use registers” as a public record of data an organisation has shared with other individuals or organisations for the purpose of research, innovation and service evaluation, and are used by some data custodians across the United Kingdom to increase transparency of data use. They typically contain information about the type of data being shared, the purpose, date of approval and name of organisation or individual using (or receiving) the data. However, information published lacks standardisation across organisations. Registers do not yet have a consistent approach and are often incomplete, updated infrequently and not accessible to the public. In this paper, we present an empirical analysis of existing data use registers in the UK and investigate accessibility, content, format and frequency of updates across health data organisations. This analysis will inform future recommendations for a data use register standard that will be published by the UK Health Data Research Alliance.
Open AccessAnalysis of Data Use Registers published by health data custodians in the UK
Transparency of how health and social care data is used by researchers is crucial to building public trust. We define “data use registers” as a public record of data an organisation has shared with other individuals or organisations for the purpose of research, innovation and service evaluation, and are used by some data custodians across the United Kingdom to increase transparency of data use. They typically contain information about the type of data being shared, the purpose, date of approval and name of organisation or individual using (or receiving) the data. However, information published lacks standardisation across organisations. Registers do not yet have a consistent approach and are often incomplete, updated infrequently and not accessible to the public. In this paper, we present an empirical analysis of existing data use registers in the UK and investigate accessibility, content, format and frequency of updates across health data organisations. This analysis will inform future recommendations for a data use register standard that will be published by the UK Health Data Research Alliance.
- Open Access
- 1 November 2019
- Published by Elsevier in Journal of Fluids and Structures
- Vol. 91, 102641
Fluid–structure interaction for highly complex, statistically defined, biological media: Homogenisation and a 3D multi-compartmental poroelastic model for brain biomechanics
- 1 November 2019
- Published by Elsevier in Journal of Fluids and Structures
- Vol. 91, 102641
Open AccessFluid–structure interaction for highly complex, statistically defined, biological media: Homogenisation and a 3D multi-compartmental poroelastic model for brain biomechanics
- 13 September 2019
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 20 (11) , 702
Author Correction: Leveraging European infrastructures to access 1 million human genomes by 2022
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 13 September 2019
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 20 (11) , 702
Author Correction: Leveraging European infrastructures to access 1 million human genomes by 2022
An amendment to this paper has been published and can be accessed via a link at the top of the paper.